These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 627526)

  • 21. Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.
    Brumfitt W; Kosmidis J; Hamilton-Miller JM; Gilchrist JN
    Antimicrob Agents Chemother; 1974 Sep; 6(3):290-9. PubMed ID: 15830475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Should cefminox substitute cefoxitin in infections caused by bacteria susceptible to both drugs?].
    Dámaso D; Burillo A; Rogero G; Losada I
    Rev Esp Quimioter; 1999 Dec; 12(4):325-31. PubMed ID: 10855011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriological investigations with a new Semisynthetic oxy-beta-lactam antibiotic LY 127935 (AUTHOR'S TRANSL)].
    Malottke R
    Infection; 1980; 8(1):43-5. PubMed ID: 6445339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibilities of gentamicin-resistant Gram-negative aerobic bacilli to cefotetan and other beta-lactams.
    Hart CA; Percival A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():95-101. PubMed ID: 6573329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefotetan: profile of in-vitro activity.
    Bauernfeind A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefotetan: a review of the microbiologic properties and antimicrobial spectrum.
    Jones RN
    Am J Surg; 1988 May; 155(5A):16-23. PubMed ID: 3287964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies with cefuroxime and cefoxitin.
    Geddes AM; McGhie D; Ball AP; Gould I
    Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of new cephamycins in the management of obstetric and gynecologic infections.
    Jones RN
    J Reprod Med; 1990 Nov; 35(11 Suppl):1070-7. PubMed ID: 2277375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro activity of cefotetan, other beta-lactams and netilmicin.
    Shah PM
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():73-8. PubMed ID: 6573326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefotetan: comparative study in vitro against 226 Gram-negative clinical isolates.
    Morel C; Vergnaud M; Langeard MM; Dupuy L
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():31-6. PubMed ID: 6573323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.
    Snepar R; Poporad G; Romano J; Levison ME
    Antimicrob Agents Chemother; 1981 Nov; 20(5):642-7. PubMed ID: 6459763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial activity of HR-756, cefoxitin and cefuroxine against multiply antibiotic-resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa.
    Legakis NJ; Kafetzis DA; Papadatos CJ; Papavassiliou JT
    Chemotherapy; 1980; 26(5):334-43. PubMed ID: 6248301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Mar; 33(3):317-21. PubMed ID: 6247313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
    Trager GM; White GW; Zimelis VM; Bryk DA; Panwalker AP
    Chemotherapy; 1981; 27(1):34-8. PubMed ID: 6260435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of the in vitro antibacterial activity of cefoxitin, cefuroxine, and cephaloridine.
    Norrby R; Brorsson JE; Seeberg S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):506-10. PubMed ID: 1259406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.